NXTAGE: a phase 1/2 study of NXT007 to assess safety, pharmacokinetics, and efficacy in hemophilia A without inhibitors

Journal:

Blood

Published:

2026-05-07

DOI:

10.1182/blood.2025031894

Affiliations:

11

Authors:

15

Go to article

Institutions	Authors	Share
Chugai Pharmaceutical Co., Ltd., Japan	5.000000	0.33
Nara Medical University, Japan	2.000000	0.13
Eulji University Hospital, Eulji University, South Korea	1.000000	0.07
Kyung Hee University Hospital at Gangdong, South Korea	1.000000	0.07
Tri-Service General Hospital, Taiwan	1.000000	0.07
Changhua Christian Hospital, Taiwan	1.000000	0.07
Taichung Veterans General Hospital, Taiwan	1.000000	0.07
National Hospital Organization Osaka National Hospital, Japan	1.000000	0.07
Tokyo Medical University, Japan	1.000000	0.07
National Taiwan University Hospital (NTUH), Taiwan	1.000000	0.07

Interested in Medical Biotechnology?